Wary pharma: AstraZeneca sours on UK

We go deep inside the Chernobyl nuclear-power plant and the surrounding exclusion zone, recounting the history of the accident on April 26 1986, and speaking with plant workers who were on shift that day. A pre-eminent Chernobyl historian discusses the lessons learned and yet to ...  Show more

We examine what our forecast model predicts so far—and consider what might change its confident prediction for one house of Congress and toss-up call for the other. Our correspondent sits down with Steve Reich, a pioneering classical composer who is nearing his 90th birthday. And ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  Show more

Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ...  Show more